Shenzhen Chipscreen Biosciences Co., Ltd.
Records under this name other than the patents Shenzhen Chipscreen Biosciences Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.
Showing 1 to 4 of 4 · Back to Shenzhen Chipscreen Biosciences Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,244,751 | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity Term ended Term ended Jun 20, 2025 · USPTO record | Term ended | Term ended Jun 20, 2025 | USPTO record |
| US 7,268,157 | Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity Term ended Term ended Jul 8, 2024 · USPTO record | Term ended | Term ended Jul 8, 2024 | USPTO record |
| US 7,550,490 | Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity Term ended Term ended Feb 2, 2024 · USPTO record | Term ended | Term ended Feb 2, 2024 | USPTO record |
| US 7,192,970 | Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity Lapsed on the fee record Ended Mar 20, 2011 · USPTO record | Lapsed on the fee record | Ended Mar 20, 2011 | USPTO record |